387 related articles for article (PubMed ID: 4369887)
21. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
Rowe M; Rooney CM; Rickinson AB; Lenoir GM; Rupani H; Moss DJ; Stein H; Epstein MA
Int J Cancer; 1985 Apr; 35(4):435-41. PubMed ID: 2985508
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
24. Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease.
Klein G
Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():783-90. PubMed ID: 169032
[No Abstract] [Full Text] [Related]
25. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
26. Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones.
Cleary ML; Epstein MA; Finerty S; Dorfman RF; Bornkamm GW; Kirkwood JK; Morgan AJ; Sklar J
Science; 1985 May; 228(4700):722-4. PubMed ID: 2986287
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.
Sculley TB; Sculley DG; Pope JH; Bornkamm GW; Lenoir GM; Rickinson AB
Intervirology; 1988; 29(2):77-85. PubMed ID: 2842274
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-positive Japanese Burkitt lymphoma.
Miyoshi I; Hiraki S; Tsubota T; Uno J; Nakamura K; Ota T; Hikita T; Hayashi K; Kataoka M; Tanaka T; Kimura I; Sairenji T; Hinuma Y
Gan; 1978 Jun; 69(3):449-50. PubMed ID: 208908
[No Abstract] [Full Text] [Related]
29. Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients.
Josephs SF; Buchbinder A; Streicher HZ; Ablashi DV; Salahuddin SZ; Guo HG; Wong-Staal F; Cossman J; Raffeld M; Sundeen J
Leukemia; 1988 Mar; 2(3):132-5. PubMed ID: 3258048
[TBL] [Abstract][Full Text] [Related]
30. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
Miller G; Coope D; Niederman J; Pagano J
J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
[TBL] [Abstract][Full Text] [Related]
31. [Epstein-Barr virus DNA in human tumor cells].
Schulte-Holthausen H; zur Hausen H
Zentralbl Bakteriol Orig A; 1972 May; 220(1):47-51. PubMed ID: 4145629
[No Abstract] [Full Text] [Related]
32. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
33. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay.
Brown TD; Klein G
IARC Sci Publ (1971); 1975; (11 Pt 1):351-6. PubMed ID: 190139
[No Abstract] [Full Text] [Related]
34. Superinfection with Epstein-Barr virus of human lymphoid cell lines of different origin.
Adams A; Klein G
Nat New Biol; 1973 Apr; 242(121):234-6. PubMed ID: 4349776
[No Abstract] [Full Text] [Related]
35. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
Tanaka A; Nonoyama M; Hampar B
Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
[No Abstract] [Full Text] [Related]
36. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
37. On the biology of Epstein-Barr virus persistence: a reappraisal.
Rickinson AB
Adv Exp Med Biol; 1990; 278():137-46. PubMed ID: 1963030
[No Abstract] [Full Text] [Related]
38. The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line.
Minowada J; Nonoyama M; Moore GE; Rauch AM; Pagano JS
Cancer Res; 1974 Aug; 34(8):1898-903. PubMed ID: 4366935
[No Abstract] [Full Text] [Related]
39. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
Wilson G; Miller G
Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286
[No Abstract] [Full Text] [Related]
40. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
Klein G; Sugden B; Leibold W; Menezes J
Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
